Monthly Archives: September 2010

Mayo Leads Global Study on Breast Drug Side Effect

September 27th, 2010 - 8:26 pm

Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women … Continue reading →

By Robert Nellis | Posted in Cancer, Research, Women's Health | Tagged , | Leave a comment

Hand Transplant Program Initiated at Mayo Clinic

September 23rd, 2010 - 10:12 am

Mayo Clinic has initiated the first clinical Hand Transplant Program in the United States and is now enrolling patients. This program offers hand transplantation as a clinically available option for patients with bilateral hand injuries or amputations. This allows patients … Continue reading →

By Amy Tieder | Posted in Transplant | Tagged , , , | Comments (2)

Inflammation Causes Some Postsurgical Neuropathies

September 22nd, 2010 - 9:09 am

A Mayo Clinic study found that nerve inflammation may cause the pain, numbness and weakness following surgical procedures that is known as postsurgical neuropathy. The development of post-surgical neuropathies is typically attributed to compression or stretching of nerves during surgery. … Continue reading →

By Elizabeth Rice | Posted in Neurology & Neurosurgery | Tagged , , , , | Comments (2)

Mayo Collaborative Study: Early Findings Show Promise Against Bone Marrow Disease

September 16th, 2010 - 4:21 pm

Mayo Clinic Cancer Center researchers and collaborators from the M.D. Anderson Cancer Center have found “marked and durable” patient benefits from an experimental drug that inhibits a mutation responsible for myelofibrosis, a serious bone marrow disease that can lead to … Continue reading →

By Robert Nellis | Posted in Cancer | Tagged , , , , | Leave a comment

Targeted Therapy Substantially Decreases Progression Rate in Patients With an Aggressive Form of Thyroid Cancer

September 16th, 2010 - 9:55 am

The drug pazopanib may help revolutionize the care of patients with metastatic, rapidly progressive differentiated thyroid cancers, say researchers at Mayo Clinic who are publishing findings of a phase II clinical trial in The Lancet Oncology. The researchers studied 37 … Continue reading →

By Adam Brase | Posted in Cancer, Research | Tagged , , , , , , | Leave a comment

Mayo-Led Researchers Discover Genetic Variants Modifying Breast Cancer Risk

September 13th, 2010 - 3:22 pm

Individuals with disrupting mutations in the BRCA1 gene are known to be at substantially increased risk of breast cancer throughout their lives. Now, discoveries from an international research team led by Mayo Clinic investigators show that some of those persons … Continue reading →

By Robert Nellis | Posted in Cancer, Research | Tagged , , , | Leave a comment

Concerns About Your Memory? Join Mayo Clinic, USA Today for Twitter Chat

September 13th, 2010 - 8:45 am

On Thursday, Sept. 16 from 1-2 p.m. EDT, Mayo Clinic (@MayoClinic) and USA Today are teaming to provide another hour-long opportunity for you to discuss health-related topics with a Mayo Clinic subject expert via Twitter. Ronald Petersen, M.D., Ph.D., (@RonPetersenMD), … Continue reading →

By Elizabeth Rice | Posted in Neurology & Neurosurgery, Research | Tagged , , , , , | Leave a comment

Medical Expert for Media – Endocrinology – Maria Collazo-Clavell, M.D.

September 13th, 2010 - 8:05 am

Maria Collazo-Clavell, M.D., expert in obesity and diabetes mellitus Speaks English and Spanish To schedule an interview, call: Media Relations Consultant Bob Nellis (507-284-5005)

By makalajohnson | Posted in Diabetes & Endocrinology | Leave a comment

Protected: Video for News Outlets

September 10th, 2010 - 4:23 pm

There is no excerpt because this is a protected post.

By Joel Streed | Posted in Uncategorized | Enter your password to view comments.

Mayo Clinic Awarded $11 Million-plus for Pharmacogenomics

September 7th, 2010 - 12:05 pm

Pharmacogenomics – the study of how medication is affected by individual genomes – is a major field of study. It allows physicians to prescribe drugs accurately and safely. One dose does not fit all. In fact, for some a standard … Continue reading →

By Robert Nellis | Posted in Uncategorized | Comments (1)